XML 153 R99.htm IDEA: XBRL DOCUMENT v3.20.4
Earnings per Share - Basic and Diluted Earnings Per Share (Details) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Numerator:                      
Net income attributable to Biogen Inc. $ 357.9 $ 701.5 $ 1,542.1 $ 1,399.1 $ 1,439.7 $ 1,545.9 $ 1,494.1 $ 1,408.8 $ 4,000.6 $ 5,888.5 $ 4,430.7
Denominator:                      
Basic earnings per share attributable to Biogen Inc. (in shares) 153.7 156.9 160.6 172.8 177.8 184.0 190.3 196.6 160.9 187.1 204.9
Effect of dilutive securities:                      
Dilutive potential common shares (in shares)                 0.4 0.3 0.4
Diluted earnings per share attributable to Biogen Inc. (in shares) 154.0 157.2 160.9 173.1 178.2 184.2 190.4 197.0 161.3 187.4 205.3
Time-vested restricted stock units                      
Effect of dilutive securities:                      
Stock options and employee stock purchase plan (in shares)                 0.2 0.2 0.3
Market stock units                      
Effect of dilutive securities:                      
Stock options and employee stock purchase plan (in shares)                 0.1 0.1 0.1
Performance stock units settled in stock                      
Effect of dilutive securities:                      
Stock options and employee stock purchase plan (in shares)                 0.1 0.0 0.0